acCELLerate - About the company
acCELLerate is an unfunded company based in Hamburg (Germany), founded in 2015 by Rosanne Joseph Anthony. It operates as a Developing cell-based bioassay kits. acCELLerate has not raised any funding yet. The company has 115 active competitors, including 30 funded and 15 that have exited. Its top competitors include companies like Bit.bio, Cellply and CytoTronics.
Company Details
acCELLerate develops bioassay kits which include cells that can be used instantly like a reagent. Frozen Instant Cells are claimed to be cryopreserved at a highly functional state and are ready-to-use without prior cultivation, passaging or even cell counting. Their service offerings include - bioassay development, cell production, and cell bank storage. Their product portfolio encompasses the following - instaCELL cytotoxicity assay kits, ARC - assay-ready cells, RRC - reporter ready cells (transfected with a luciferase reporter gene which is expressed upon activation of stress pathway) and TRC - transfection-ready cells. These products can be used for cell-based assays in high-throughput screening, toxicology assessment, clinical stage bioassays or post-marketing quality control.
- Website
- www.accellerate.me/
- Social
- Email ID
- *****@accellerate.me
- Phone Number
- +1 **********, +49 **********
- Registered Address
- Osterfeldstr. 12-14, 22529 Hamburg
Key Metrics
Founded Year
2015
Location
Hamburg, Germany
Stage
Unfunded
Ranked
16th among 115 active competitors
Employee Count
37 as on Jun 30, 2026
Legal entities associated with acCELLerate
acCELLerate is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
acCELLerate GmbH CIN: K1101_HRB131393 , Germany, Active | Apr 07, 2014 | - | - |
Sign up to download acCELLerate's company profile
acCELLerate's funding and investors
acCELLerate has not raised any funding rounds yet.
acCELLerate's founders and board of directors
Founder? Claim ProfileThe founders of acCELLerate is Rosanne Joseph Anthony.
Here are the details of acCELLerate's key team members:
- Rosanne Joseph Anthony: Co-Founder & Managing Director of acCELLerate.
View details of acCELLerate's Founder profiles and Board Members
acCELLerate's employee count trend
acCELLerate has 37 employees as of Jun 26. Here is acCELLerate's employee count trend over the years:
Uncover acCELLerate's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
acCELLerate's Competitors and alternates
Top competitors of acCELLerate include Bit.bio, Cellply and CytoTronics. Here is the list of Top 10 competitors of acCELLerate, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Bit.bio 2016, Cambridge (United Kingdom), Series C | Manufacturer of programmed human cells for research and drug discovery | $266M | 68/100 | |
2nd | Developer of in-vitro diagnostic products for the detection of cancer | $16.4M | 60/100 | ||
3rd |  CytoTronics 2015, Boston (United States), Series A | Developer of cell-based assays for drug discovery | $22.8M | 56/100 | |
4th | Kiyatec 2005, Pendleton (United States), Series C | Develops 3D phenotypic cell-based assays and diagnostic solutions for prediction of patients’ response to cancer drug treatment | $29.5M | 55/100 | |
5th | Developer of 3D cell culture products for drug discovery | $4.1M | 49/100 | ||
6th | Pelago Bioscience 2013, Solna (Sweden), Seed | Assay services for use in the determination and quantification of drug-target interactions | - | 48/100 | |
7th |  Cytotheryx 2018, Rochester (United States), Series A | Developer of human hepatocytes for research and clinical applications | $60M | 47/100 | |
8th | StemBioSys 2010, San Antonio (United States), Series A | Cell culture technology company advancing regenerative medicine and drug discovery | $14.5M | 45/100 | |
9th |  Nanocrine 2018, Frederick (United States), Seed | Provider of a cell analysis and drug design tool for researchers | $300K | 43/100 | |
10th | Supplier of ion channel, GPCR and neural signaling tools | - | - | 41/100 | |
16th | acCELLerate 2015, Hamburg (Germany), Unfunded | Developing cell-based bioassay kits | - | - | 39/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on acCELLerate's competitors? Click here to see the top ones
acCELLerate's Investments and acquisitions
acCELLerate has made no investments or acquisitions yet.
Reports related to acCELLerate
Here is the latest report on acCELLerate's sector:
News related to acCELLerate
Media has covered acCELLerate for 1 event in last 1 year, It was about company updates.
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about acCELLerate
Explore our recently published companies
- Saalfo Tech - Mysuru based, 1990 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Uvtcpl - India based, Unfunded company
- Diamondexch99 - Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Funding Raised company
- Dash - Atlanta based, 2025 founded, Unfunded company
